5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 338.00▼ | 347.00▼ |
MA10 | N/A | N/A | N/A | 347.00▼ | 366.50▼ |
MA20 | N/A | N/A | N/A | 351.50▼ | 369.05▼ |
MA50 | N/A | N/A | N/A | 373.96▼ | 357.77▼ |
MA100 | N/A | N/A | N/A | 372.51▼ | N/A |
MA200 | N/A | N/A | N/A | 380.86▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -1.757▼ | -9.079▼ |
RSI | N/A | N/A | N/A | 27.612▼ | 41.331▼ |
STOCH | N/A | N/A | N/A | 17.899▼ | 15.442▼ |
WILL %R | N/A | N/A | N/A | -70.000 | -86.957▼ |
CCI | N/A | N/A | N/A | -120.035▼ | -163.267▼ |
MA | $AREC.L Price Crossed Above MA(13) | Set Alert |
Monday, July 04, 2022 12:33 AM
Arecor Therapeutics PLC (AIM:AREC) will give a presentation on the Phase I clinical trial of its AT278 ultra-concentrated ultra-rapid ...
|
Wednesday, June 29, 2022 04:45 AM
AREC) ("American Resources" or the "Company"), a next generation and socially responsible supplier of rare earth and critical elements, carbon and advanced carbon materials to the new ...
|
Wednesday, June 22, 2022 09:38 PM
But you can significantly boost your returns by picking above-average stocks. To wit, the Arecor Therapeutics plc (LON:AREC) share price is 57% higher than it was a year ago, much better than the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
04/07/22 | 335.00 | 335.00 | 320.00 | 335.00 | 210 |
01/07/22 | 335.00 | 335.00 | 333.00 | 335.00 | 1,600 |
30/06/22 | 335.00 | 335.00 | 333.00 | 335.00 | 1,600 |
29/06/22 | 335.00 | 335.00 | 333.00 | 335.00 | 1,600 |
28/06/22 | 350.00 | 350.00 | 336.00 | 350.00 | 150 |
27/06/22 | 350.00 | 354.00 | 350.00 | 350.00 | 4,224 |
24/06/22 | 345.00 | 350.00 | 345.00 | 345.00 | 1,000 |
23/06/22 | 350.00 | 350.00 | 345.00 | 345.00 | 1,000 |
22/06/22 | 370.00 | 370.00 | 350.00 | 370.00 | 771 |
21/06/22 | 370.00 | 370.00 | 359.00 | 370.00 | 640 |
|
|
||||
|
|
||||
|
|